Founder and Chairman of Allegro Investment Fund, L.P., a registered Cayman Islands Investment Fund that is managed by Allegro Investment Inc. Located in Menlo Park, CA, Allegro primarily invests in growth stage private companies and supports its portfolio by providing growth capital as well as strategic, operating and financial expertise.
Mr. Encrantz has actively led investments in and operation of a variety of companies for over 30 years. He has led the growth and development of both early stage companies and established businesses in a wide variety of fields.
Mr. Encrantz is currently Chairman of AnaMar AB, ClosingCorp Inc, Evolve Controls, LLC, Nclear Inc, Alestra Ltd., Koncentra Holding AB and the Koncentra Verkstads AB group. He is also a director of GovX, Inc, Oxymetal SAS and several other companies.
Mr. Encrantz previously worked at ASEA AB, Sweden (now ABB Ltd.), as its deputy General Counsel 1979-1981, as Finance Manager 1981-1984, and during 1984-1990 in Switzerland and the UK as Business Area manager responsible for ABB’s Commodity Trading and Counter Trading group. Prior to this, he worked at Skandia Insurance Co, Sweden as its General Counsel and in private law practice.
Mr. Encrantz holds a law degree (Magna cum Laude) from Uppsala University, Sweden.
What is Staffan Encrantz's net worth?
The estimated net worth of Staffan Encrantz is at least $3.25 million as of November 29th, 2023. Mr. Encrantz owns 871,373 shares of Sight Sciences stock worth more than $3,250,221 as of November 21st. This net worth evaluation does not reflect any other investments that Mr. Encrantz may own. Learn More about Staffan Encrantz's net worth.
How do I contact Staffan Encrantz?
Has Staffan Encrantz been buying or selling shares of Sight Sciences?
Staffan Encrantz has not been actively trading shares of Sight Sciences during the last ninety days. Most recently, on Wednesday, November 29th, Staffan Encrantz bought 3,223 shares of Sight Sciences stock. The stock was acquired at an average cost of $3.50 per share, with a total value of $11,280.50. Following the completion of the transaction, the director now directly owns 871,373 shares of the company's stock, valued at $3,049,805.50. Learn More on Staffan Encrantz's trading history.
Who are Sight Sciences' active insiders?
Are insiders buying or selling shares of Sight Sciences?
In the last year, Sight Sciences insiders bought shares 4 times. They purchased a total of 312,494 shares worth more than $996,880.56. In the last year, insiders at the sold shares 24 times. They sold a total of 3,060,674 shares worth more than $17,902,282.88. The most recent insider tranaction occured on October, 21st when insider Matthew Link sold 21,831 shares worth more than $122,471.91. Insiders at Sight Sciences own 28.9% of the company.
Learn More about insider trades at Sight Sciences. Information on this page was last updated on 10/21/2024.
